300039 深市 上海凯宝

                                上海凯宝药业股份有限公司

                2024 年半年度非经营性资金占用及其他关联资金往来情况汇总表

编制单位：上海凯宝药业股份有限公司                                                                                                                      单位：万元

                                                                      上市公  2024 年期  2024 年度占  2024 年  2024 年度  2024 年期

非经营性资金          资金占用方名称          占用方与上市公司的  司核算  初占用资  用累计发生  度占用资  偿还累计  末占用资  占用形成原因    占用性质
占用                                                  关联关系      的会计    金余额    金额（不含  金的利息  发生金额    金余额

                                                                      科目                利息）    (如有)

控股股东、实
际控制人及其
附属企业

小计                          -                          -            -                                                                    -            -

前控股股东、
实际控制人及
其附属企业

小计                          -                          -            -                                                                    -            -

其他关联方及
附属企业
小计

总计                          -                          -            -                                                                    -            -

                                                                      上市公  2024 年期  2024 年度往  2024 年  2024 年度  2024 年期                往来性质（经
其它关联资金          资金往来方名称          往来方与上市公司的  司核算  初往来资  来累计发生  度往来资  偿还累计  末往来资  往来形成原因  营性往来、非
往来                                                  关联关系      的会计    金余额    金额（不含  金的利息  发生金额    金余额                  经营性往来）
                                                                      科目                利息）    (如有)

控股股东、实
际控制人及其

  附属企业


              上海顺捷医药有限公司              孙子公司            其他应                521.25                521.25            拆借利息      非经营性往来
                                                                    收款

              上海顺捷医药有限公司              孙子公司            应收账  37,659.33  37,562.75            62,051.71  13,170.37  销售商品      经营性往来
上市公司的子                                                        款

公司及其附属                                                        预付账

    企业      上海凯宝健康科技有限公司          子公司              款                        0.04                  0.04            采购商品      经营性往来

              上海凯合交医疗科技有限公司        子公司              预付账                  7.50                  7.50            采购商品      经营性往来
                                                                    款

              上海凯合交医疗科技有限公司        子公司              其他应      1.11                              1.11            代垫款        非经营性往来
                                                                    收款

              北京盈科瑞生物医药研究有限公司    公司子公司间接参股  预付账                162.96                162.96            采购研发支出  经营性往来
其他关联方及                                                        款

 其附属企业  盈科瑞（横琴）药物研究院有限公司  公司子公司间接参股  预付账                140.00                140.00            采购研发支出  经营性往来
                                                                    款

    总计                      -                          -            -    37,660.44  38,394.50            62,884.57  13,170.37                      -

本表已于 2024 年 8 月 28 日获董事会批准。

法定代表人：穆竟伟                                          主管会计工作负责人：任立旺                                  会计机构负责人（会计主管人员）：李雅茹